NCT06910553View on ClinicalTrials.gov

IBD Pregnancy Registry

RecruitingOBSERVATIONAL
Enrollment

832

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

September 30, 2032

Study Completion Date

September 30, 2032

Conditions
Inflammatory Bowel Disease (IBD)
Interventions
OTHER

Non-exposed group

Pregnant individuals with IBD who are not exposed to an IBD pharmacotherapy during pregnancy

DRUG

Exposed to IBD pharmacotherapy during pregnancy

Pregnant individuals with IBD who are exposed to an IBD pharmacotherapy during pregnancy

Trial Locations (1)

28401

RECRUITING

PPD, Wilmington

Sponsors

Lead Sponsor

CorEvitas
All Listed Sponsors
lead

CorEvitas

NETWORK

NCT06910553 - IBD Pregnancy Registry | Biotech Hunter | Biotech Hunter